Top 3 Health Care Stocks That May Collapse In Q2
Top 3 Health Care Stocks That May Collapse In Q2
As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.
Here's the latest list of major overbought players in this sector.
OncoCyte Corporation (NASDAQ:OCX)
- On April 11, Oncocyte announced a $15.8 million private placement of securities priced at-the-market under Nasdaq rules. The company's stock gained around 4% over the past five days and has a 52-week high of $6.80 .
- RSI Value: 73.87
- OCX Price Action: Shares of OncoCyte rose 1.2% to close at $2.9650 on Thursday.
Curis, Inc. (NASDAQ:CRIS)
- On April 5, Curis reported inducement grants under NASDAQ Listing Rule 5635(c)(4). The company's stock gained around 59% over the past month and has a 52-week high of $17.49.
- RSI Value: 75.26
- CRIS Price Action: Shares of Curis gained 4.1% to close at $15.90 on Thursday.
Revolution Medicines, Inc. (NASDAQ:RVMD)
- On April 9, the company announced the publication of a research paper on RMC-6236 in Cancer Discovery. The company's stock gained around 25% over the past five days and has a 52-week high of $38.73.
- RSI Value: 72.27
- RVMD Price Action: Shares of Revolution Medicines gained 2.5% to close at $37.41 on Thursday.
Read More: Fear & Greed Index Moves To 'Greed' Zone Following PPI Data; Nasdaq record Sharp Gains
As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
截至2024年4月12日，醫療保健行業的三隻股票可能會向將動量視爲交易決策關鍵標準的投資者發出真正的警告。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.
RSI 是一種動量指標，它比較股票在價格上漲的日子和價格下跌的日子的走勢。與股票的價格走勢相比，它可以讓交易者更好地了解股票在短期內的表現。根據Benzinga Pro的數據，當相對強弱指數高於70時，資產通常被視爲超買。
Here's the latest list of major overbought players in this sector.
以下是該行業主要超買參與者的最新名單。
OncoCyte Corporation (NASDAQ:OCX)
OncoCyte 公司（納斯達克股票代碼：OCX）
- On April 11, Oncocyte announced a $15.8 million private placement of securities priced at-the-market under Nasdaq rules. The company's stock gained around 4% over the past five days and has a 52-week high of $6.80 .
- RSI Value: 73.87
- OCX Price Action: Shares of OncoCyte rose 1.2% to close at $2.9650 on Thursday.
- 4月11日，Oncocyte宣佈根據納斯達克規則私募市場定價的1,580萬美元證券。該公司的股票在過去五天中上漲了約4％，並且 52 周高點爲 6.80 美元 。
- RSI 值：73.87
- OCX價格走勢：週四，OncoCyte的股價上漲1.2％，收於2.9650美元。
Curis, Inc. (NASDAQ:CRIS)
Curis, Inc.（納斯達克股票代碼：CRIS）
- On April 5, Curis reported inducement grants under NASDAQ Listing Rule 5635(c)(4). The company's stock gained around 59% over the past month and has a 52-week high of $17.49.
- RSI Value: 75.26
- CRIS Price Action: Shares of Curis gained 4.1% to close at $15.90 on Thursday.
- 4月5日，庫里斯報告了納斯達克上市規則5635（c）（4）下的激勵補助金。該公司的股票在過去一個月中上漲了約59％， 創下 52 周新高 爲17.49美元。
- RSI 值：75.26
- CRIS價格走勢：週四，Curis的股價上漲4.1％，收於15.90美元。
Revolution Medicines, Inc. (NASDAQ:RVMD)
Revolution Medicines, Inc.（納斯達克股票代碼：RVMD）
- On April 9, the company announced the publication of a research paper on RMC-6236 in Cancer Discovery. The company's stock gained around 25% over the past five days and has a 52-week high of $38.73.
- RSI Value: 72.27
- RVMD Price Action: Shares of Revolution Medicines gained 2.5% to close at $37.41 on Thursday.
- 4 月 9 日，該公司宣佈在《癌症發現》中發表一篇關於 RMC-6236 的研究論文。該公司的股票在過去五天中上漲了約25％，並且 52 周高點 爲38.73美元。
- 相對強弱指數值：72.27
- RVMD價格走勢：週四，Revolution Medicines的股價上漲2.5％，收於37.41美元。
Read More: Fear & Greed Index Moves To 'Greed' Zone Following PPI Data; Nasdaq record Sharp Gains
閱讀更多： PPI數據公佈後，恐懼與貪婪指數移至 “貪婪” 區域；納斯達克創下大幅上漲紀錄
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧